Correlation Between Pasithea Therapeutics and Surrozen Warrant
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Surrozen Warrant at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Surrozen Warrant into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Surrozen Warrant, you can compare the effects of market volatilities on Pasithea Therapeutics and Surrozen Warrant and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Surrozen Warrant. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Surrozen Warrant.
Diversification Opportunities for Pasithea Therapeutics and Surrozen Warrant
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Pasithea and Surrozen is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Surrozen Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Surrozen Warrant and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Surrozen Warrant. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Surrozen Warrant has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Surrozen Warrant go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and Surrozen Warrant
Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to under-perform the Surrozen Warrant. But the stock apears to be less risky and, when comparing its historical volatility, Pasithea Therapeutics Corp is 4.32 times less risky than Surrozen Warrant. The stock trades about -0.04 of its potential returns per unit of risk. The Surrozen Warrant is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 1.97 in Surrozen Warrant on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Surrozen Warrant or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 91.67% |
| Values | Daily Returns |
Pasithea Therapeutics Corp vs. Surrozen Warrant
Performance |
| Timeline |
| Pasithea Therapeutics |
| Surrozen Warrant |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Solid
Pasithea Therapeutics and Surrozen Warrant Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pasithea Therapeutics and Surrozen Warrant
The main advantage of trading using opposite Pasithea Therapeutics and Surrozen Warrant positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Surrozen Warrant can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surrozen Warrant will offset losses from the drop in Surrozen Warrant's long position.| Pasithea Therapeutics vs. Cue Biopharma | Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. Inhibrx | Pasithea Therapeutics vs. Molecular Partners AG |
| Surrozen Warrant vs. Surrozen | Surrozen Warrant vs. Celularity | Surrozen Warrant vs. Quantum Si incorporated | Surrozen Warrant vs. Humacyte |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |